Invention Grant
- Patent Title: Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections
- Patent Title (中): 靶向聚谷氨酸治疗表皮葡萄球菌及相关感染
-
Application No.: US13554245Application Date: 2012-07-20
-
Publication No.: US08623371B2Publication Date: 2014-01-07
- Inventor: Michael Otto , Stanislava Kocianova
- Applicant: Michael Otto , Stanislava Kocianova
- Applicant Address: US DC Washington
- Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
- Current Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K39/085
- IPC: A61K39/085

Abstract:
Immunogenic compositions and methods for eliciting an immune response against S. epidermidis and other related staphylococci are provided. The immunogenic compositions can include immunogenic conjugates of poly-γ-glutamic acid (such as γDLPGA) polypeptides of S. epidermidis, or related staphylococci that express a γPGA polypeptide. The γPGA conjugates elicit an effective immune response against S. epidermidis, or other staphylococci, in subjects to which the conjugates are administered. A method of treating an infection caused by a Staphylococcus organism that expresses cap genes is also disclosed. The method can include selecting a subject who is at risk of or has been diagonosed with the infection by the Staphylococcus organism which expresses γPGA from the cap genes. Further, the expression of a γPGA polypeptide by the organism can then be altered.
Public/Granted literature
- US20120301481A1 TARGETING POLY-GAMMA-GLUTAMIC ACID TO TREAT STAPHYLOCOCCUS EPIDERMIDIS AND RELATED INFECTIONS Public/Granted day:2012-11-29
Information query